Literature DB >> 18761712

Serotonin 1A receptors in human and monkey prefrontal cortex are mainly expressed in pyramidal neurons and in a GABAergic interneuron subpopulation: implications for schizophrenia and its treatment.

Julián de Almeida1, Guadalupe Mengod.   

Abstract

Serotonin 1A (5-HT(1A)) receptors are found in high densities in prefrontal cortex. However, their distribution within cortical cell populations is unknown in both humans and primates. We used double in situ hybridization histochemistry to quantify the percentage of glutamatergic and GABAergic neurons expressing 5-HT(1A) receptors in human and monkey prefrontal cortex. Moreover, in the case of the monkey, we also quantified the parvalbumin and calbindin GABAergic subpopulations expressing this receptor. 5-HT(1A) receptor mRNAs were expressed in about 80% of glutamatergic neurons in external layers II and upper III, and in around 50% in layer VI; they were also present in approximately 20% of GABAergic neurons in both species. Although they were found in up to 43% of the calbindin cell subpopulation they were rarely present in parvalbumin cells in monkey prefrontal cortex. The knowledge of the phenotype of the prefrontal cortex (PFC) cells expressing 5-HT(1A) will help understanding serotonin actions in PFC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18761712     DOI: 10.1111/j.1471-4159.2008.05649.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  24 in total

1.  Dorsolateral prefrontal γ-aminobutyric acid in men predicts individual differences in rash impulsivity.

Authors:  Frederic Boy; C John Evans; Richard A E Edden; Andrew D Lawrence; Krish D Singh; Masud Husain; Petroc Sumner
Journal:  Biol Psychiatry       Date:  2011-07-14       Impact factor: 13.382

2.  5-HT1A parital agonism and 5-HT7 antagonism restore episodic memory in subchronic phencyclidine-treated mice: role of brain glutamate, dopamine, acetylcholine and GABA.

Authors:  Mei Huang; Sunoh Kwon; Lakshmi Rajagopal; Wenqi He; Herbert Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2018-07-31       Impact factor: 4.530

3.  Serotonin 1B Receptors Regulate Prefrontal Function by Gating Callosal and Hippocampal Inputs.

Authors:  Celia Kjaerby; Jegath Athilingam; Sarah E Robinson; Jillian Iafrati; Vikaas S Sohal
Journal:  Cell Rep       Date:  2016-12-13       Impact factor: 9.423

4.  Discovery of Natural Product-Derived 5-HT1A Receptor Binders by Cheminfomatics Modeling of Known Binders, High Throughput Screening and Experimental Validation.

Authors:  Man Luo; Terry-Elinor Reid; Xiang Simon Wang
Journal:  Comb Chem High Throughput Screen       Date:  2015       Impact factor: 1.339

5.  Fluoxetine (prozac) and serotonin act on excitatory synaptic transmission to suppress single layer 2/3 pyramidal neuron-triggered cell assemblies in the human prefrontal cortex.

Authors:  Gergely Komlósi; Gábor Molnár; Márton Rózsa; Szabolcs Oláh; Pál Barzó; Gábor Tamás
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

Review 6.  Identifying serotonergic mechanisms underlying the corticolimbic response to threat in humans.

Authors:  Patrick M Fisher; Ahmad R Hariri
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

7.  Aripiprazole differentially regulates the expression of Gad67 and γ-aminobutyric acid transporters in rat brain.

Authors:  Nina Peselmann; Andrea Schmitt; Peter J Gebicke-Haerter; Mathias Zink
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09-12       Impact factor: 5.270

Review 8.  Antipsychotic treatment modulates glutamate transport and NMDA receptor expression.

Authors:  Mathias Zink; Susanne Englisch; Andrea Schmitt
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-12       Impact factor: 5.270

Review 9.  Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.

Authors:  Pau Celada; Analía Bortolozzi; Francesc Artigas
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

Review 10.  Transcriptional dys-regulation in anxiety and major depression: 5-HT1A gene promoter architecture as a therapeutic opportunity.

Authors:  Paul R Albert; Laura M Fiori
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.